-
Is Steel Authority of India a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Kunal Singla
- Category: Market
No Comments
Steel Authority of India Q1 FY27: revenue Rs 26,451 crore, PAT Rs 1,644 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Is Sundram Fasteners a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Kunal Singla
- Category: Market
Sundram Fasteners Q1 FY27: revenue Rs 1,855 crore, PAT Rs 169 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Is Sumitomo Chemical India a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Kunal Singla
- Category: Market
Sumitomo Chemical India Q1 FY27: revenue Rs 1,111 crore, PAT Rs 215 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Is Tata Chemicals a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Lakshit Sharma
- Category: Market
Tata Chemicals Q1 FY27: revenue Rs 4,311 crore, PAT Rs 60 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Is PCBL Chemical a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Kunal Singla
- Category: Market
PCBL Chemical Q1 FY27: revenue Rs 2,478 crore, PAT Rs 155 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Is Suven Life Sciences a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Lakshit Sharma
- Category: Market
Suven Life Sciences Q1 FY27: revenue Rs 11 crore, loss Rs 128 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Is Poonawalla Fincorp a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Kunal Singla
- Category: Market
Poonawalla Fincorp Q1 FY27: revenue Rs 2,337 crore, PAT Rs 308 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Is Sanofi Consumer Healthcare India a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Lakshit Sharma
- Category: Market
Sanofi Consumer Healthcare India Q1 FY27: revenue Rs 236 crore, PAT Rs 69 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Is PTC India Financial Services a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Kunal Singla
- Category: Market
PTC India Financial Services Q1 FY27: revenue Rs 103 crore, PAT Rs 40 crore. Full results breakdown and whether the stock is a buy at current levels.
-
Is Reliance Power a Good Buy After Its Q1 FY27 Results?
- September 4, 2026
- Posted by: Lakshit Sharma
- Category: Market
Reliance Power Q1 FY27: revenue Rs 2,104 crore, PAT Rs 65 crore. Full results breakdown and whether the stock is a buy at current levels.